Author: Sood, Shivani; Bhatia, Gurpreet Kaur; Seth, Prachi; Kumar, Pawan; Kaur, Jagjit; Gupta, Vidisha; Punia, Sandeep; Tuli, Hardeep Singh
Title: Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone Cord-id: oeu95tih Document date: 2021_2_18
ID: oeu95tih
Snippet: PURPOSE OF REVIEW: The widespread respiratory disease of virus known as severe acute respiratory syndrome–coronavirus 2019 (SAR-CoV-2) had infected more than 200 countries and caused pandemic and havoc in the world. RECENT FINDINGS: The genome of the virus was sequenced rapidly to study its mechanism, epidemiology, drugs, and vaccines. Many drugs and vaccines are being studied by researchers to treat and prevent the SARS-CoV-2. Favipiravir and dexamethasone are repurposed drugs which showed th
Document: PURPOSE OF REVIEW: The widespread respiratory disease of virus known as severe acute respiratory syndrome–coronavirus 2019 (SAR-CoV-2) had infected more than 200 countries and caused pandemic and havoc in the world. RECENT FINDINGS: The genome of the virus was sequenced rapidly to study its mechanism, epidemiology, drugs, and vaccines. Many drugs and vaccines are being studied by researchers to treat and prevent the SARS-CoV-2. Favipiravir and dexamethasone are repurposed drugs which showed therapeutic potential and pharmaceutical efficacy against SARS-CoV-2. SUMMARY: The review describes the path of favipiravir and dexamethasone from chemistry to mechanisms of action to combat SARS-CoV-2. In addition, the potential side effects are also summarized to study their potential to control corona virus 2019.
Search related documents:
Co phrase search for related documents- acute respiratory distress syndrome and adrenal gland: 1
- acute respiratory distress syndrome and adrenal insufficiency: 1, 2, 3, 4
- acute respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute respiratory distress syndrome and lung damage cause: 1, 2, 3, 4
- acute respiratory distress syndrome and lung damage responsible: 1, 2
- acute respiratory distress syndrome and lupus autoimmune disease: 1
Co phrase search for related documents, hyperlinks ordered by date